12:00 AM
Feb 13, 2012
 |  BC Week In Review  |  Company News  |  Deals

AGI Therapeutics, Aravis Therapeutics deal

AGI said shareholders had tendered 54 million shares (80.2%) under Aravis' offer to acquire...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >